Next Chapter M&A | Home System Overview AquaScience Hub
Buyer Dossier

Evoqua Water Technologies (Xylem)

Prepared for AquaScience
6Fit
AquaScience • Lawrence "Larry" Casey

Buyer Profile

Company
Xylem Inc. (f/k/a Evoqua Water Technologies)
Ticker
NYSE: XYL
Merger
Xylem acquired Evoqua in 2023 for $7.5B
2025 Revenue
$9.0 Billion (up 6%)
2025 Adj. EPS
$5.08 (up 19%)
Market Cap
>$32 Billion (late 2025)
CEO
Matthew Pine
Corp Dev Contact
Tracy Evans, Director of Corporate Development

Key Contacts

NameTitleRelevanceEmail
Matthew PineCEO, XylemStrategic direction; M&A growth thesis
Bill GroganCFO, XylemFinancial approvals; deal economics
Tracy EvansDirector, Corporate DevelopmentPrimary M&A contact; deal origination and execution
Karen PulickDirector, Global IT & M&A IntegrationIntegration planning; tuck-in execution expertise
Keith BuettnerVP, Investor Relations & FP&AFinancial framing; IR context for deal announcements

Strategic Fit

Xylem — the world's largest pure-play water technology company after absorbing Evoqua — is pursuing the $401 billion global water infrastructure market. Their post-integration "80/20" strategic focus concentrates resources on the highest-value customers and geographies. The Mountain West is an underpenetrated whitespace for Xylem's North American service footprint, and AquaScience fills it precisely.

Evoqua's legacy was built on North American water treatment service contracts — an installed base, recurring service revenue, and digital monitoring relationships. AquaScience's Wyoming operations mirror that model at a regional scale. For Xylem, this is a tuck-in that extends geographic service coverage without integration complexity: same product logic, same customer relationship model, new territory.

Xylem has the integration infrastructure to execute small acquisitions efficiently — Karen Pulick's continued M&A integration leadership role confirms the organization is structurally prepared for add-ons. A company that absorbed a $7.5 billion acquisition in 2023 will have minimal friction closing a Mountain West water treatment operator. The question for Xylem is fit and footprint, not execution capacity.

Approach Strategy

Call Opener: "Tracy, Xylem has been building out North American water treatment service coverage since the Evoqua integration — we have a Wyoming water treatment operator in process that fills a Mountain West whitespace in your service footprint. Small tuck-in, clean asset, recurring service contracts. Wanted to get this in front of you before we broaden the process."

1
Wyoming is a gap in your Mountain West coverage. Xylem's 150+ country footprint still has regional density gaps in the Intermountain West. AquaScience is an established operator with community-embedded customer relationships — the type of local presence Xylem's scale alone cannot replicate.
2
Evoqua DNA — service contracts and recurring revenue. AquaScience operates exactly the service contract model Evoqua was built on: installed base, recurring treatment service revenue, local technical relationships. This is a natural extension of Xylem's Evoqua-inherited playbook into a new region.
3
Tuck-in, not transformation. AquaScience is a clean, focused water treatment operator with no legacy liabilities. For a company that executed a $7.5B integration, this is a rounding error on complexity but a meaningful addition to regional service density and recurring revenue.

Pipeline History

DateActivityOutcomeStatus
Mar 2026Dossier prepared; Xylem/Evoqua identified as Tier 1 strategic buyerResearch completeComplete
Outreach to Tracy Evans, Corp DevPendingNext Step
NDA & teaser deliveryPending
Management introductionPending